Marking a significant milestone in the global effort to expand access to advanced HIV therapies, STEERLife (the life sciences division of STEER World), and Bionpharma Inc. today announced that ...
Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation oral macrocyclic ...
ISTURISA® (osilodrostat) is indicated for the treatment of adult patients with Cushing's disease who have persistent or recurrent hypercortisolism after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback